Marco Metra

Professor

Institute of Cardiology, University of Brescia

Expertise

Heart Failure Standards & Guidelines Imaging and Diagnosis Inherited and Congenital Cardiac Conditions Heterogeneous Populations CV Disease in Special Populations

Biography

Marco Metra is Full Professor of Cardiology and Director of the Institute of Cardiology of the Civil Hospital and University of Brescia, Italy, and Editor-in-Chief of the European Journal of Heart Failure and Senior Consulting Editor of the European Heart Journal.

Prof Metra has been principal investigator and member of the Executive or Steering Committees of many trials in patients with heart failure. His research is focused on heart failure with, as main areas of interest, β-blocker therapy and, more recently, the assessment and treatment of the patients with acute heart failure.

He has co-chaired with Prof. Teerlink, San Francisco, CA, the phase IIB Pre-RELAX-AHF and the phase III RELAX-AHF randomized placebo controlled trials in patients with acute heart failure and is chairing the current RELAX-AHF-2 trial, which has as primary end-points the effects of serelaxin on the 180-days mortality and on in-hospital worsening heart failure. He is also member of the Executive Committee or Data Monitoring Committees of many major trials regarding the treatment of heart failure.

He is the author of more than 400 articles in peer-reviewed journals.